首页> 外文OA文献 >Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region.
【2h】

Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region.

机译:通过代表性差异分析鉴定位于BRCA2区域内的胰腺癌的纯合缺失。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Homozygous deletions have been central to the discovery of several tumor-suppressor genes, but their finding has often been either serendipitous or the result of a directed search. A recently described technique [Lisitsyn, N., Lisitsyn, N. & Wigler, M. (1993) Science 259, 946-951] held out the potential to efficiently discover such events in an unbiased manner. Here we present the application of the representational difference analysis (RDA) to the study of cancer. We cloned two DNA fragments that identified a homozygous deletion in a human pancreatic adenocarcinoma, mapping to a 1-centimorgan region at chromosome 13q12.3 flanked by the markers D13S171 and D13S260. Interestingly, this lies within the 6-centimorgan region recently identified as the BRCA2 locus of heritable breast cancer susceptibility. This suggests that the same gene may be involved in multiple tumor types and that its function is that of a tumor suppressor rather than that of a dominant oncogene.
机译:纯合子缺失一直是发现几种肿瘤抑制基因的关键,但它们的发现常常是偶然的或直接搜索的结果。最近描述的技术[Lisitsyn,N.,Lisitsyn,N。和Wigler,M。(1993)Science 259,946-951]展现了以无偏见的方式有效发现这样的事件的潜力。在这里,我们介绍代表性差异分析(RDA)在癌症研究中的应用。我们克隆了两个DNA片段,这些片段在人胰腺腺癌中鉴定出纯合缺失,映射到染色体13q12.3处的1-centimorgan区,两侧是标记D13S171和D13S260。有趣的是,这位于最近被确定为可遗传性乳腺癌易感性的BRCA2基因座的6厘摩区域。这表明同一基因可能参与多种肿瘤类型,其功能是抑癌基因,而不是显性癌基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号